Code of Civil Procedure section 425.13, subdivision (a),
We issued an alternative writ of mandate to respondent court, citing, inter alia, College Hospital, which rejected an attempt to amend a complaint to allege punitive damages based on a showing far stronger than plaintiff's. Our alternative writ directed respondent court to reconsider and reverse its ruling, or show cause before this court why a peremptory writ should not issue directing it to do so. Respondent court held a hearing in compliance with the alternative writ but concluded it had properly granted the motion to amend the complaint to allege punitive damages.
Because plaintiff's counsel's declaration and the three letters are insufficient as a matter of law to support the motion to amend the complaint to allege punitive damages, we direct respondent court to set aside its order and enter a new order denying the motion.
Plaintiff filed a complaint on July 13, 2011, against various defendants, including the Hospital.
On August 20, 2012, plaintiff filed a motion to amend her complaint against the Hospital to allege three new causes of action: (1) violation of Health and Safety Code section 24170 et seq. (the Protection of Human Subjects in Medical Experimentation Act); (2) fraud; and (3) negligence per se. In addition, plaintiff moved for leave to amend to seek punitive damages against the Hospital in the manner required by section 425.13.
The sworn evidence presented in support of the motion to amend consisted of a declaration from plaintiff's counsel and three attached letters from the Hospital's institutional review board (IRB)
The three letters relied upon by plaintiff were on the Hospital's letterhead, addressed to Dr. Mesiwala. Each letter pertained to "Protocol Study: OP-1 Putty: An FDA approved device under the Humanitarian Use Device (HUD) regulations." The letters were signed by either the chairperson or vice-chair of the Hospital's IRB.
The first letter, dated February 4, 2009, gave approval of "your request" for annual renewal by the IRB of the OP-1 Putty protocol study. The letter
The second letter from the IRB to Dr. Mesiwala was dated February 4, 2010. This letter also related to "your request" for annual renewal of the OP-1 Putty protocol study. Information submitted showed 17 subjects, all of whom were still alive and in followup. The renewal was for 10 months, and Dr. Mesiwala was again directed to immediately notify the IRB of any unexpected ill effects on patients.
The final letter to Dr. Mesiwala was dated January 25, 2012. The IRB approved closing the study "since patients are beyond normal follow-up care." The letter asked what Dr. Mesiwala considered to be normal followup, when the last followup was done, and how "are the other patients doing generally?" Dr. Mesiwala was directed to submit "this paperwork" to the IRB coordinator.
The proposed amended complaint sought to add causes of action 12 through 14 against the Hospital. The 12th and 13th causes of action sought punitive damages based on the Hospital's malicious, fraudulent, and oppressive conduct toward plaintiff and alleged plaintiff was unaware she was one of at least 17 patients enrolled in a five-year research project to which she never consented. The 12th cause of action alleged violation of Health and Safety Code section 24170 et seq., the Protection of Human Subjects in Medical Experimentation Act, by approving a research project which "randomized patients" to test the safety and efficacy of OP-1 Putty on patients. The 13th cause of action for fraud alleged the Hospital concealed plaintiff's participation in the OP-1 Putty research project.
The Hospital argued the motion to amend was untimely. It also filed evidentiary objections to the declaration of plaintiff's counsel and to the three attached documents. On the merits, the Hospital opposed the motion to
Plaintiff argued she had substantiated that she was enrolled as an unwitting test subject in the Hospital's OP-1 Putty research project. The Hospital is subject to punitive damages for engaging in conduct that constitutes conscious disregard of the rights or safety of others by enrolling plaintiff in nonconsensual human experimentation.
On September 12, 2012, respondent court overruled the Hospital's evidentiary objections, found the motion to amend timely, and granted the motion to amend the complaint to add the 12th through 14th causes of action, with punitive damage allegations as to the 12th and 13th causes of action.
The Hospital filed the instant petition arguing, in part, that plaintiff failed to meet her burden of showing a substantial probability of prevailing on a claim of punitive damages under section 425.13. The Hospital contends the three letters from the IRB to Dr. Mesiwala at most establish there was a research project, but plaintiff did not submit any competent evidence the project was secret, that she was enrolled in the project, or that its existence was concealed from her. In addition, nothing in the documents show any misrepresentation by the Hospital, any intent to deceive plaintiff, or reliance. The letters do not establish any evidence of malice or oppression by the Hospital.
Section 425.13, subdivision (a)
"[S]ubstantiation of a proposed punitive damages claim occurs only where the factual recitals are made under penalty of perjury and set forth competent admissible evidence within the personal knowledge of the declarant. (See §§ 437c, subds. (b) & (d), 2015.5.) Consistent with the legislative intent to protect health care defendants from the drastic effects of unwarranted punitive damage claims, the entire package of materials submitted in support of the
The premise of plaintiff's punitive damages claim is that the letters from the IRB to Dr. Mesiwala demonstrate the Hospital was conducting a secret research project, plaintiff was unwittingly enrolled in the project, and plaintiff would not have consented to participation. Plaintiff's showing in support of the motion to amend the complaint contains no competent evidence to substantiate any of these claims.
We begin by reiterating that the burden was on plaintiff to substantiate her claim for punitive damages with "factual recitals" which were "made under penalty of perjury" and "set forth competent admissible evidence within the personal knowledge of the declarant." (College Hospital, supra, 8 Cal.4th at pp. 719-720.) College Hospital made clear that plaintiff's own pleading is entitled to no evidentiary weight in the analysis. (Id. at p. 720, fn. 7.)
The only sworn evidence before respondent court was the declaration by plaintiff's counsel. Counsel's declaration established personal knowledge of only one fact relevant to the issue of punitive damages — that the three letters on Hospital letterhead were a part of the discovery received from Stryker Biotech. Counsel set forth no personal knowledge of the existence of a secret research study conducted by the Hospital, plaintiff's participation in the study, or her lack of consent.
The February 2009 letter asks Dr. Mesiwala to submit information "as soon as possible in order to better understand your study" (italics added), regarding the number of patients "enrolled nationally," whether "randomization" should be continued if the procedure is effective, and if there is statistical evidence pertaining to the study. The 2009 and 2010 letters direct Dr. Mesiwala to immediately communicate if there are any "unexpected ill effects on the patient(s) as a result of this study."
Plaintiff's counsel's declaration is not based on any personal knowledge of conduct by the Hospital regarding plaintiff, so it necessarily does not amount to clear and convincing proof of the elements of malice. The letters relied on by plaintiff also fail, as a matter of law, to show malice. Nothing in the letters suggests the Hospital engaged in, or was complicit in, a secret study conducted without knowledge of the participants. The IRB letters to Dr. Mesiwala make no reference of any kind to plaintiff. They show nothing more than the IRB's performance of its official function in connection with Dr. Mesiwala's study of OP-1 Putty. The letters reflect the IRB's consideration of the submissions by Dr. Mesiwala, questions the IRB directed to Dr. Mesiwala, and directions to him to immediately report any unexpected adverse results. The IRB's conduct, as reflected in the letters, lacks any hint of the necessary element of "despicable conduct" required for malice on the theory of "conscious disregard of the rights or safety of others." (See College
Finally, we reject plaintiff's contention that our decision in Pomona Valley Hospital Medical Center v. Superior Court, supra, 209 Cal.App.4th 687 compels a different result. Plaintiff quotes the following language from the "Facts and Procedural History" portion of our opinion summarizing the IRB provisions of the Hospital's bylaws: "The stated purpose of the IRB is to provide assurance to the medical staff, the governing board, and the community that the rights and welfare of patients involved in investigational studies are protected and patients are fully informed about the risks involved in the investigational study before they consent. The IRB is charged with responsibility for the evaluation and approval of proposed investigational studies, as well as monitoring ongoing studies. It is the IRB's duty to require that each patient be adequately informed of the nature of the study and the possible side effects, risks and consequences of an investigational drug or device. It is also the IRB's duty to require that each patient sign an informed consent." (Pomona Valley Hospital Medical Center v. Superior Court, supra, 209 Cal.App.4th at p. 691.)
We reject plaintiff's contention that the above quoted language compels a finding that she satisfied her obligation of showing a substantial probability of prevailing on her punitive damages claim against the Hospital. The language correctly describes the duties of the IRB set forth in the Hospital's bylaws. The record presented to respondent court contains no evidence that the IRB failed to monitor whether Dr. Mesiwala, the person "primarily responsible for the conduct of a medical experiment," properly obtained informed consent from the patients in the study. (Health & Saf. Code, § 24176 [person who is "primarily responsible for conduct of a medical experiment" must obtain a subject's informed consent]; see Daum v. SpineCare Medical Group, Inc. (1997) 52 Cal.App.4th 1285, 1319 [61 Cal.Rptr.2d 260] ["The statutes and federal regulations on which the Daums rely to establish the duty of disclosure clearly hold `the investigator' (21 C.F.R. § 50.20 (1996)) or the `person who is primarily responsible for the conduct of a medical experiment' (Health & Saf. Code, § 24176) responsible for obtaining the subject's informed consent."].)
The petition for writ of mandate is granted. A peremptory writ shall issue directing respondent court to vacate that portion of its order of September 12, 2012, granting plaintiff's motion to amend the complaint to add punitive
Turner, P. J., and Ferns, J.,